DE3687007D1 - 6-thioxanthinderivate. - Google Patents

6-thioxanthinderivate.

Info

Publication number
DE3687007D1
DE3687007D1 DE8686100544T DE3687007T DE3687007D1 DE 3687007 D1 DE3687007 D1 DE 3687007D1 DE 8686100544 T DE8686100544 T DE 8686100544T DE 3687007 T DE3687007 T DE 3687007T DE 3687007 D1 DE3687007 D1 DE 3687007D1
Authority
DE
Germany
Prior art keywords
ethyl
compounds
activity
thioxanthinderivate
reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686100544T
Other languages
English (en)
Other versions
DE3687007T2 (de
Inventor
Peter Hofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of DE3687007D1 publication Critical patent/DE3687007D1/de
Publication of DE3687007T2 publication Critical patent/DE3687007T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/22—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8686100544T 1985-02-07 1986-01-17 6-thioxanthinderivate. Expired - Lifetime DE3687007T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/699,254 US4710503A (en) 1985-02-07 1985-02-07 6-thioxanthine derivatives

Publications (2)

Publication Number Publication Date
DE3687007D1 true DE3687007D1 (en) 1992-12-03
DE3687007T2 DE3687007T2 (de) 1993-06-03

Family

ID=24808534

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686100544T Expired - Lifetime DE3687007T2 (de) 1985-02-07 1986-01-17 6-thioxanthinderivate.

Country Status (16)

Country Link
US (2) US4710503A (de)
EP (1) EP0191313B1 (de)
JP (2) JPH0780882B2 (de)
KR (1) KR930002492B1 (de)
CN (1) CN1013676B (de)
AT (1) ATE81858T1 (de)
AU (1) AU570142B2 (de)
CA (1) CA1275288C (de)
DE (1) DE3687007T2 (de)
DK (1) DK161964C (de)
FI (1) FI84180C (de)
IL (1) IL77430A (de)
IN (1) IN161914B (de)
NO (1) NO163569C (de)
NZ (1) NZ214653A (de)
ZA (1) ZA859805B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
US5310916A (en) * 1988-07-19 1994-05-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
AU5436790A (en) * 1989-04-19 1990-11-16 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Sulfer-containing xanthine derivatives as adenosin antagonists
CA2028235C (en) 1989-10-20 1997-01-21 Fumio Suzuki Condensed purine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6025361A (en) * 1994-12-13 2000-02-15 Euro-Celtique, S.A. Trisubstituted thioxanthines
EP0799040B1 (de) * 1994-12-13 2003-08-20 Euroceltique S.A. Dreifachsubstituierte thioxanthine
ATE247116T1 (de) * 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
WO1996018400A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US6316423B1 (en) 1996-04-10 2001-11-13 The United States Of America As Represented By The Departmant Of Health And Human Services Method of treating ischemic, hypoxic and anoxic brain damage
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5744473A (en) * 1996-09-16 1998-04-28 Euro-Celtique, S.A. PDE IV inhibitors: "bis-compounds"
AR039385A1 (es) * 2002-04-19 2005-02-16 Astrazeneca Ab Derivados de tioxantina como inhibidores de la mieloperoxidasa
SE0302756D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel Compounds
SE0402591D0 (sv) * 2004-10-25 2004-10-25 Astrazeneca Ab Novel use
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
TW200804383A (en) 2006-06-05 2008-01-16 Astrazeneca Ab New compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE587119A (fr) * 1959-10-22 1960-07-29 May & Baker Ltd Nouveaux dérivés de la thioxanthine, leur préparation et les compositions pharmaceutiques qui les contiennent.
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines

Also Published As

Publication number Publication date
JPS61183287A (ja) 1986-08-15
FI860285A0 (fi) 1986-01-21
KR930002492B1 (ko) 1993-04-02
DE3687007T2 (de) 1993-06-03
ATE81858T1 (de) 1992-11-15
AU570142B2 (en) 1988-03-03
EP0191313B1 (de) 1992-10-28
JP2888273B2 (ja) 1999-05-10
CN86101050A (zh) 1986-11-12
AU5184086A (en) 1986-08-14
DK161964B (da) 1991-09-02
NZ214653A (en) 1988-07-28
NO163569C (no) 1990-06-20
NO860424L (no) 1986-08-08
JPH0780882B2 (ja) 1995-08-30
KR860006464A (ko) 1986-09-11
NO163569B (no) 1990-03-12
FI84180B (fi) 1991-07-15
DK161964C (da) 1992-02-10
DK33286A (da) 1986-08-08
ZA859805B (en) 1986-08-27
IN161914B (de) 1988-02-27
FI860285A (fi) 1986-08-08
US4710503A (en) 1987-12-01
EP0191313A1 (de) 1986-08-20
JPH0899882A (ja) 1996-04-16
DK33286D0 (da) 1986-01-22
CA1275288C (en) 1990-10-16
FI84180C (fi) 1991-10-25
US4820709A (en) 1989-04-11
CN1013676B (zh) 1991-08-28
IL77430A (en) 1988-10-31

Similar Documents

Publication Publication Date Title
DE3687007D1 (en) 6-thioxanthinderivate.
JO1224B1 (en) Derivatives of SIS, endo-azabicilco- (3,3, zero) -octane-3-carboxylic acid for their preparation, agents containing these compounds and methods of use.
UA7088A1 (uk) Спосіб одержання солі 2-(2-гідроксіетоксі)етіламіна та 3,6-діхлор-2-метоксібензойної кислоти
AU2979789A (en) Gas-phase reaction of 1,1,1-trifluorochloroethane with hydrogen fluoride to produce 1,1,1,2-tetrafluoroethane
AU548324B2 (en) Biotin antagonist composition for use on skin and hair
ZA85441B (en) 6,6-ethylene-15,16-methylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactones,processes for the production thereof,and pharmaceutical preparations containing them
IE822064L (en) Composition containing human insulin and c-peptide
NZ221328A (en) A synergistic combination of t-pa and a prostaglandin, being pge, or a compound of formula i
AU1918583A (en) Antiviral 5-halovinyl-2'-deoxyuridines
GR3005131T3 (de)
PH21295A (en) Octahydroindolizine compounds useful as analgesics
IL89331A0 (en) Preparation of 3,3-diarylacrylic acid amides
ES2014187A6 (es) Procedimiento para preparar levo y dextro-dropropizina.
SU1121940A1 (ru) Этиловый эфир [3-метил-5- 2′ -оксифенил)-1,2,4-триазолил-1] уксусной кислоты, обладающий психостимулирующим действием
ES8707489A1 (es) Un procedimiento para preparar un derivado de carbaciclina
SU1167881A1 (ru) Фенилгидразид морфолинодиэтилуксусной кислоты, обладающий противотуберкулезным действием
SU1146989A1 (ru) ГИДРОХЛОРИД ОРТО-БРОМАНИЛИДА β -ДИЭТИЛАМИНОПРОПИОНОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЙ АНЕСТЕЗИРУЮЩУЮ АКТИВНОСТЬ
SU1233456A1 (ru) Способ получения замещенных n-[(1,3,5-триазин-2-ил)аминокарбонил]бензолсульфонамидов
ES8707203A1 (es) Procedimiento para purificar una 5-pirimidincarboxamida
ES2000960A6 (es) Un procedimiento para preparar n(1-ciclohexenilmetil-2-pirrolidinilmetil)-8-etilsulfonil-1,5-benzodioxepan-6-carboxamida
SU1198912A1 (ru) Арилгидразиды 2-бутилгекс-2-еновой кислоты, проявляющие противотуберкулезную активность, и способ их получения
JPS53139782A (en) Immobilized enzyme reactor of double bed, continuous pulsating moving bed type
SU1262908A1 (ru) Гидрохлорид 1-(2'-этоксиэтил)-4-фенил-4-пропионилоксипиперидина, обладающий анальгетической активностью
SU1269456A1 (ru) 4-п-изопропоксифенил-2-пирролидон, обладающий противосудорожной активностью
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов

Legal Events

Date Code Title Description
8364 No opposition during term of opposition